Login / Signup

Diffusion-weighted MRI predicts the histologic response for neoadjuvant therapy in patients with pancreatic cancer: a prospective study (DIFFERENT trial).

Ken-Ichi OkadaManabu KawaiSeiko HironoFumiyoshi KojimaKensuke TaniokaMasaki TeradaMotoki MiyazawaYuji KitahataYoshifumi IwahashiMasaki UenoShinya HayamiShin-Ichi MurataToshio ShimokawaHiroki Yamaue
Published in: Langenbeck's archives of surgery (2020)
Post-treatment whole-tumor ADC value may be a predictor of R0 resectability in patients with BRPC. Tumor cell destruction rate is indicated by the difference between pre-/post-treatment ADC values. This difference is strongly affected by the pre-treatment ADC value. The cutoff value of ADC at the site of vascular contact could not discriminate R0 resectability.
Keyphrases
  • diffusion weighted
  • contrast enhanced
  • diffusion weighted imaging
  • magnetic resonance imaging
  • stem cells
  • computed tomography
  • squamous cell carcinoma
  • cell therapy
  • study protocol
  • bone marrow
  • phase ii